The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

T. Zuberbier; W. Aberer; R. Asero; C. Bindslev-Jensen; Z. Brzoza; G.W. Canonica; M.K. Church; L.F. Ensina; A. Giménez-Arnau; K. Godse; M. Gonçalo; C. Grattan; J. Hebert; M. Hide; A. Kaplan; A. Kapp; A.H. Abdul Latiff; P. Mathelier-Fusade; M. Metz; A. Nast; S.S. Saini; M. Sánchez-Borges; P. Schmid-Grendelmeier; F.E.R. Simons; P. Staubach; G. Sussman; E. Toubi; G.A. Vena; B. Wedi; X.J. Zhu; M. Maurer

doi:10.5114/dr.2015.51433

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2015
vol. 102

Send email

Copy url:

abstract:

The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

T. Zuberbier

,

W. Aberer

,

R. Asero

,

C. Bindslev-Jensen

,

Z. Brzoza

,

G.W. Canonica

,

M.K. Church

,

L.F. Ensina

,

A. Giménez-Arnau

,

K. Godse

,

M. Gonçalo

,

C. Grattan

,

J. Hebert

,

M. Hide

,

A. Kaplan

,

A. Kapp

,

A.H. Abdul Latiff

,

P. Mathelier-Fusade

,

M. Metz

,

A. Nast

,

S.S. Saini

,

M. Sánchez-Borges

,

P. Schmid-Grendelmeier

,

F.E.R. Simons

,

P. Staubach

,

G. Sussman

,

E. Toubi

,

G.A. Vena

,

B. Wedi

,

X.J. Zhu

,

M. Maurer

Przegl Dermatol 2015, 102, 155–179

DOI: https://doi.org/10.5114/dr.2015.51433

Online publish date: 2015/05/06

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Dermatology Review/Przegląd Dermatologiczny. 2015;102(2):155-179. doi:10.5114/dr.2015.51433.

APA

Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z.,  & Canonica, G. et al. (2015). The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Dermatology Review/Przegląd Dermatologiczny, 102(2), 155-179. https://doi.org/10.5114/dr.2015.51433

Chicago

Zuberbier, T., W. Aberer, R. Asero, C. Bindslev-Jensen, Z. Brzoza, G.W. Canonica,  and M.K. Church et al. 2015. "The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update". Dermatology Review/Przegląd Dermatologiczny 102 (2): 155-179. doi:10.5114/dr.2015.51433.

Harvard

Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G., Church, M., Ensina, L., Giménez-Arnau, A., Godse, K., Gonçalo, M., Grattan, C., Hebert, J., Hide, M., Kaplan, A., Kapp, A., Latiff, A., Mathelier-Fusade, P., Metz, M., Nast, A., Saini, S., Sánchez-Borges, M., Schmid-Grendelmeier, P., Simons, F., Staubach, P., Sussman, G., Toubi, E., Vena, G., Wedi, B., Zhu, X.,  and Maurer, M. (2015). The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Dermatology Review/Przegląd Dermatologiczny, 102(2), pp.155-179. https://doi.org/10.5114/dr.2015.51433

MLA

Zuberbier, T. et al. "The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update." Dermatology Review/Przegląd Dermatologiczny, vol. 102, no. 2, 2015, pp. 155-179. doi:10.5114/dr.2015.51433.

Vancouver

Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica G et al. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Dermatology Review/Przegląd Dermatologiczny. 2015;102(2):155-179. doi:10.5114/dr.2015.51433.

PlumX metrics:

This guideline is the result of a systematic literature review using the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA2LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The life-time prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).

keywords:

The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

angioedema, consensus, hives, urticaria, wheal